文献速递冠心病外科瓣膜外科

接受肾脏替代治疗患者心脏手术的全国结局

National Outcomes of Cardiac Surgery in Patients Receiving Kidney Replacement Therapy.
PubMed 文献 · Ann Thorac Surg · 2024-10-19

该研究基于澳大利亚2010至2019年注册数据库链接,纳入114496例成人心脏手术,其中长期透析1241例、肾移植298例。透析患者30天死亡调整OR为4.17,肾移植患者为3.52,均显著高于一般心脏手术人群。

要点

  • 透析患者心脏手术后30天死亡调整OR为4.17(95%CI 3.31-5.25)。
  • 肾移植患者死亡调整OR为3.52(95%CI 2.16-5.72),预后同样不佳。
  • 透析患者瓣膜联合冠状动脉旁路移植术死亡率达18.78/100例手术。

核心结论

  • 尽管透析和肾移植队列手术时年龄更轻,其手术死亡率仍更高。
  • 透析患者瓣膜联合冠状动脉旁路移植术死亡率较一般人群高3.7至5倍。
  • 透析患者是心脏手术高危人群,肾移植受者预后同样较差。

研究设计与样本

  • 基于人群的观察性队列研究,链接心脏手术注册库与肾脏替代治疗注册库。
  • 纳入澳大利亚2010至2019年接受心脏手术的成人患者,共114496例手术。
  • 其中长期透析患者1241例,肾移植受者298例。
  • 采用多因素logistic回归估计30天手术死亡及其他术后结局的调整风险。

主要发现

  • 透析患者30天死亡调整OR为4.17(95%CI 3.31-5.25),高于一般心脏手术人群。
  • 肾移植受者30天死亡调整OR为3.52(95%CI 2.16-5.72)。
  • 透析患者瓣膜联合冠状动脉旁路移植术死亡率为18.78/100例手术(95%CI 13.37-25.25)。
  • 肾移植受者瓣膜联合冠状动脉旁路移植术死亡率为14.00/100例手术(95%CI 5.82-26.74)。
  • 透析患者所有其他测量结局的调整比值比均高于一般人群。

临床怎么用

  • 对透析和肾移植患者行心脏手术前应充分评估高风险并加强围术期管理。
  • 瓣膜联合冠状动脉旁路移植术在透析和肾移植患者中死亡风险尤其高,需谨慎决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies estimating risks after cardiac surgery for patients receiving kidney replacement therapy have been limited by the size and generalizability of those cohorts. This study used data linked between registries to estimate short-term postoperative outcomes for large patient cohorts receiving kidney replacement therapy at the time of surgery. METHODS: This population-based observational cohort study included adult patients who had undergone cardiac surgery in Australia between 2010 and 2019. Patient data were linked with a kidney replacement therapy registry to identify cohorts accurately and extract relevant data. Multivariable logistic regression estimated the risk of operative (30-day) mortality and other postoperative outcomes for long-term dialysis and functioning kidney transplant cohorts compared with each other and the general cardiac surgical population. RESULTS: Of 114,496 surgeries, 1241 were in patients receiving long-term dialysis and 298 for those with a kidney transplant. The mortality rate was highest for patients who had valve-with-coronary artery bypass grafting for patients undergoing dialysis (18.78 per 100 surgeries; 95% CI, 13.37-25.25) and transplant recipients (14.00 per 100 surgeries; 95% CI, 5.82-26.74). Dialysis-treated patients had higher adjusted odds of mortality (odds ratio [OR], 4.17; 95% CI, 3.31-5.25) and all other measured outcomes than did the general population. Kidney transplant recipients had similarly elevated odds of mortality (OR, 3.52; 95% CI, 2.16-5.72). CONCLUSIONS: Despite the younger age of the dialysis and transplant cohorts at surgery, operative mortality rates were higher, and the mortality rates for valve-with-coronary artery bypass grafting were 3.7- to 5-fold higher than those in the general population. Patients undergoing dialysis were a high risk for cardiac surgery, and the prognosis for kidney transplant recipients was similarly poor.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Keuskamp D, Davies CE, Baker RA, et al. National Outcomes of Cardiac Surgery in Patients Receiving Kidney Replacement Therapy. Ann Thorac Surg. 2024. PMID: 39433230. doi:10.1016/j.athoracsur.2024.09.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。